Structural features of human immunoglobulin G that determine isotype- specific differences in complement activation

doi:10.1084/jem.178.2.661

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Tao, M. H.
	Articles by Morrison, S. L.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Tao, M. H.
	Articles by Morrison, S. L.


Social Bookmarking

	What's this?

ARTICLES

Structural features of human immunoglobulin G that determine isotype- specific differences in complement activation

MH Tao, RI Smith and SL Morrison
Department of Microbiology and Molecular Genetics, University of California, Los Angeles 90024.

Although very similar in sequence, the four subclasses of human immunoglobulin G (IgG) differ markedly in their ability to activate complement. Glu318-Lys320-Lys322 has been identified as a key binding motif for the first component of complement, C1q, and is present in all isotypes of Ig capable of activating complement. This motif, however, is present in all subclasses of human IgG, including those that show little (IgG2) or even no (IgG4) complement activity. Using point mutants of chimeric antibodies, we have identified specific residues responsible for the differing ability of the IgG subclasses to fix complement. In particular, we show that Ser at position 331 in gamma 4 is critical for determining the inability of that isotype to bind C1q and activate complement. Additionally, we provide further evidence that levels of C1q binding do not necessarily correlate with levels of complement activity, and that C1q binding alone is not sufficient for complement activation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Baudino, L., Nimmerjahn, F., Shinohara, Y., Furukawa, J.-I., Petry, F., Verbeek, J. S., Nishimura, S.-I., Ravetch, J. V., Izui, S. (2008). Impact of a Three Amino Acid Deletion in the CH2 Domain of Murine IgG1 on Fc-Associated Effector Functions. J. Immunol. 181: 4107-4112 [Abstract] [Full Text]
Tawara, T., Hasegawa, K., Sugiura, Y., Harada, K., Miura, T., Hayashi, S., Tahara, T., Ishikawa, M., Yoshida, H., Kubo, K., Ishida, I., Kataoka, S. (2008). Complement Activation Plays a Key Role in Antibody-Induced Infusion Toxicity in Monkeys and Rats. J. Immunol. 180: 2294-2298 [Abstract] [Full Text]
Kretz-Rommel, A., Qin, F., Dakappagari, N., Cofiell, R., Faas, S. J., Bowdish, K. S. (2008). Blockade of CD200 in the Presence or Absence of Antibody Effector Function: Implications for Anti-CD200 Therapy. J. Immunol. 180: 699-705 [Abstract] [Full Text]
Lu, Y., Harding, S. E., Michaelsen, T. E., Longman, E., Davis, K. G., Ortega, A., Grossmann, J. G., Sandlie, I., Garcia de la Torre, J. (2007). Solution Conformation of Wild-Type and Mutant IgG3 and IgG4 Immunoglobulins Using Crystallohydrodynamics: Possible Implications for Complement Activation. Biophys. J 93: 3733-3744 [Abstract] [Full Text]
Kanda, Y., Yamada, T., Mori, K., Okazaki, A., Inoue, M., Kitajima-Miyama, K., Kuni-Kamochi, R., Nakano, R., Yano, K., Kakita, S., Shitara, K., Satoh, M. (2007). Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Glycobiology 17: 104-118 [Abstract] [Full Text]
Dall'Acqua, W. F., Cook, K. E., Damschroder, M. M., Woods, R. M., Wu, H. (2006). Modulation of the Effector Functions of a Human IgG1 through Engineering of Its Hinge Region. J. Immunol. 177: 1129-1138 [Abstract] [Full Text]
McGreal, E. P., Rosas, M., Brown, G. D., Zamze, S., Wong, S. Y.C., Gordon, S., Martinez-Pomares, L., Taylor, P. R. (2006). The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology 16: 422-430 [Abstract] [Full Text]
Hinton, P. R., Xiong, J. M., Johlfs, M. G., Tang, M. T., Keller, S., Tsurushita, N. (2006). An Engineered Human IgG1 Antibody with Longer Serum Half-Life. J. Immunol. 176: 346-356 [Abstract] [Full Text]
Novak, J., Tomana, M., Shah, G.R., Brown, R., Mestecky, J. (2005). Heterogeneity of IgG Glycosylation in Adult Periodontal Disease. J. Dent. Res. 84: 897-901 [Abstract] [Full Text]
Cunningham, P. N., Quigg, R. J. (2005). Contrasting Roles of Complement Activation and Its Regulation in Membranous Nephropathy. J. Am. Soc. Nephrol. 16: 1214-1222 [Abstract] [Full Text]
Taylor, P. R., Zamze, S., Stillion, R. J., Wong, S. Y. C., Gordon, S., Martinez-Pomares, L. (2004). Development of a specific system for targeting protein to metallophilic macrophages. Proc. Natl. Acad. Sci. USA 101: 1963-1968 [Abstract] [Full Text]
Feng, J. Q., Mozdzanowska, K., Gerhard, W. (2002). Complement Component C1q Enhances the Biological Activity of Influenza Virus Hemagglutinin-Specific Antibodies Depending on Their Fine Antigen Specificity and Heavy-Chain Isotype. J. Virol. 76: 1369-1378 [Abstract] [Full Text]
Montano, R. F., Morrison, S. L. (2002). Influence of the Isotype of the Light Chain on the Properties of IgG. J. Immunol. 168: 224-231 [Abstract] [Full Text]
Hezareh, M., Hessell, A. J., Jensen, R. C., van de Winkel, J. G. J., Parren, P. W. H. I. (2001). Effector Function Activities of a Panel of Mutants of a Broadly Neutralizing Antibody against Human Immunodeficiency Virus Type 1. J. Virol. 75: 12161-12168 [Abstract] [Full Text]
Idusogie, E. E., Presta, L. G., Gazzano-Santoro, H., Totpal, K., Wong, P. Y., Ultsch, M., Meng, Y. G., Mulkerrin, M. G. (2000). Mapping of the C1q Binding Site on Rituxan, a Chimeric Antibody with a Human IgG1 Fc. J. Immunol. 164: 4178-4184 [Abstract] [Full Text]
Guan, L., Wims, L. A., Kane, R. R., Smuckler, M. B., Morrison, S. L., Hawthorne, M. F. (1998). Homogeneous immunoconjugates for boron neutron-capture therapy: Design, synthesis, and preliminary characterization. Proc. Natl. Acad. Sci. USA 95: 13206-13210 [Abstract] [Full Text]
Kozlowski, L. M., Li, W., Goldschmidt, M., Levinson, A. I. (1998). In Vivo Inflammatory Response to a Prototypic B Cell Superantigen: Elicitation of an Arthus Reaction by Staphylococcal Protein A. J. Immunol. 160: 5246-5252 [Abstract] [Full Text]
Wright, A., Morrison, S. L. (1998). Effect of C2-Associated Carbohydrate Structure on Ig Effector Function: Studies with Chimeric Mouse-Human IgG1 Antibodies in Glycosylation Mutants of Chinese Hamster Ovary Cells. J. Immunol. 160: 3393-3402 [Abstract] [Full Text]
Berge, A., Kihlberg, B.-M., Sjoholm, A. G., Bjorck, L. (1997). Streptococcal Protein H Forms Soluble Complement-activating Complexes with IgG, but Inhibits Complement Activation by IgG-coated Targets. J. Biol. Chem. 272: 20774-20781 [Abstract] [Full Text]
Ettinger, R., Browning, J.�L., Michie, S.�A., van�Ewijk, W., McDevitt, H.�O. (1996). Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion�protein. Proc. Natl. Acad. Sci. USA 93: 13102-13107 [Abstract] [Full Text]